Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05049616 · ClinicalTrials.gov registry record · Phase 4
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT05049616 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 70 participants.
The verdict
NCT05049616, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a combined pill of Angiotensin-converting enzyme (ACE) inhibitors (a medication that helps relax your veins and arteries to lower your blood pressure) with diuretics (sometimes called water pills, help rid your body of salt and water) will control blood pressure better than a different blood pressure medication of calcium channel blocker (lower your blood pressure by preventing calcium from entering the cells of your heart and arteries). Both medications are part of our usual care for high blood pressure after delivery.
Interventions
- DRUG NIFEdipine ER
- DRUG ACE Inhibitors and Diuretics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2023-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05049616
The ClinicalTrials.gov registry entry for NCT05049616 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NIFEdipine ER is the first listed.
NCT05049616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05049616 about?
NCT05049616 is a clinical study titled "Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension". The purpose of this study is to see if a combined pill of Angiotensin-converting enzyme (ACE) inhibitors (a medication that helps relax your veins and arteries to lower your blood pressure) with diuretics (sometimes called water pills, help rid your body of salt and water) will control blood pressur...
What is the current status of trial NCT05049616?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2021-10-18. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT05049616?
The interventions under investigation include: NIFEdipine ER (DRUG), ACE Inhibitors and Diuretics (DRUG).
Who is sponsoring clinical trial NCT05049616?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.